Sebestyén, E.; Csige, D.; Antal-Szalmás, P.; Horváth, Á.; Végh, E.; Soós, B.; Pethő, Z.; Bodnár, N.; Hamar, A.; Bodoki, L.;
et al. Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis. Biomolecules 2025, 15, 648.
https://doi.org/10.3390/biom15050648
AMA Style
Sebestyén E, Csige D, Antal-Szalmás P, Horváth Á, Végh E, Soós B, Pethő Z, Bodnár N, Hamar A, Bodoki L,
et al. Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis. Biomolecules. 2025; 15(5):648.
https://doi.org/10.3390/biom15050648
Chicago/Turabian Style
Sebestyén, Enikő, Dóra Csige, Péter Antal-Szalmás, Ágnes Horváth, Edit Végh, Boglárka Soós, Zsófia Pethő, Nóra Bodnár, Attila Hamar, Levente Bodoki,
and et al. 2025. "Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis" Biomolecules 15, no. 5: 648.
https://doi.org/10.3390/biom15050648
APA Style
Sebestyén, E., Csige, D., Antal-Szalmás, P., Horváth, Á., Végh, E., Soós, B., Pethő, Z., Bodnár, N., Hamar, A., Bodoki, L., Kacsándi, D., Földesi, R., Kalina, E., Nagy, G., Kerekes, G., Nagy, B., Jr., Hodosi, K., Szamosi, S., Árkosy, P.,
... Szekanecz, É.
(2025). Effects of Tofacitinib Therapy on Circulating Tumour-Associated Antigens and Their Relationship with Clinical, Laboratory and Vascular Parameters in Rheumatoid Arthritis. Biomolecules, 15(5), 648.
https://doi.org/10.3390/biom15050648
